{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Noblesville",
      "state": "IN",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73297",
      "recalling_firm": "Pharmakon Pharmaceuticals",
      "address_1": "14450 Getz Rd",
      "address_2": "N/A",
      "postal_code": "46060-3303",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "IN and IL",
      "recall_number": "D-0871-2016",
      "product_description": "Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride,  Rx, total volume 1 mL, This is a compounded drug, CII, IV Use, syringe, Pharmakon Pharmaceuticals, NDC 45183-0322-78.",
      "product_quantity": "75 Syringes",
      "reason_for_recall": "Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.",
      "recall_initiation_date": "20160211",
      "center_classification_date": "20160525",
      "termination_date": "20170516",
      "report_date": "20160601",
      "code_info": "Lot #: E52418EV11C, Exp 03/19/2016"
    }
  ]
}